table of content
1 Introduction to Research & Analysis Reports
1.1 Cell-Based Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-Based Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell-Based Immunotherapy Overall Market Size
2.1 Global Cell-Based Immunotherapy Market Size: 2022 VS 2029
2.2 Global Cell-Based Immunotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell-Based Immunotherapy Players in Global Market
3.2 Top Global Cell-Based Immunotherapy Companies Ranked by Revenue
3.3 Global Cell-Based Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cell-Based Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell-Based Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell-Based Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cell-Based Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell-Based Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell-Based Immunotherapy Market Size Markets, 2022 & 2029
4.1.2 Autologous Cellular Immunotherapy
4.1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
4.1.4 Dendritic Cell-based Vaccine Therapy
4.2 By Type - Global Cell-Based Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Cell-Based Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Cell-Based Immunotherapy Revenue, 2024-2029
4.2.3 By Type - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell-Based Immunotherapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Cell-Based Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Cell-Based Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Cell-Based Immunotherapy Revenue, 2024-2029
5.2.3 By Application - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cell-Based Immunotherapy Market Size, 2022 & 2029
6.2 By Region - Global Cell-Based Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Cell-Based Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Cell-Based Immunotherapy Revenue, 2024-2029
6.2.3 By Region - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cell-Based Immunotherapy Revenue, 2018-2029
6.3.2 US Cell-Based Immunotherapy Market Size, 2018-2029
6.3.3 Canada Cell-Based Immunotherapy Market Size, 2018-2029
6.3.4 Mexico Cell-Based Immunotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cell-Based Immunotherapy Revenue, 2018-2029
6.4.2 Germany Cell-Based Immunotherapy Market Size, 2018-2029
6.4.3 France Cell-Based Immunotherapy Market Size, 2018-2029
6.4.4 U.K. Cell-Based Immunotherapy Market Size, 2018-2029
6.4.5 Italy Cell-Based Immunotherapy Market Size, 2018-2029
6.4.6 Russia Cell-Based Immunotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cell-Based Immunotherapy Market Size, 2018-2029
6.4.8 Benelux Cell-Based Immunotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cell-Based Immunotherapy Revenue, 2018-2029
6.5.2 China Cell-Based Immunotherapy Market Size, 2018-2029
6.5.3 Japan Cell-Based Immunotherapy Market Size, 2018-2029
6.5.4 South Korea Cell-Based Immunotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cell-Based Immunotherapy Market Size, 2018-2029
6.5.6 India Cell-Based Immunotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cell-Based Immunotherapy Revenue, 2018-2029
6.6.2 Brazil Cell-Based Immunotherapy Market Size, 2018-2029
6.6.3 Argentina Cell-Based Immunotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, 2018-2029
6.7.2 Turkey Cell-Based Immunotherapy Market Size, 2018-2029
6.7.3 Israel Cell-Based Immunotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cell-Based Immunotherapy Market Size, 2018-2029
6.7.5 UAE Cell-Based Immunotherapy Market Size, 2018-2029
7 Cell-Based Immunotherapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Cell-Based Immunotherapy Major Product Offerings
7.1.4 Novartis Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Cell-Based Immunotherapy Major Product Offerings
7.2.4 Gilead Sciences Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Cell-Based Immunotherapy Major Product Offerings
7.3.4 AbbVie Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Cell-Based Immunotherapy Major Product Offerings
7.5.4 Amgen Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cell-Based Immunotherapy Major Product Offerings
7.6.4 AstraZeneca Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Cell-Based Immunotherapy Major Product Offerings
7.7.4 Biogen Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Major Product Offerings
7.8.4 Boehringer Ingelheim Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Company Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Cell-Based Immunotherapy Major Product Offerings
7.9.4 Eli Lilly and Company Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Eli Lilly and Company Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Cell-Based Immunotherapy Major Product Offerings
7.10.4 GSK Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Cell-Based Immunotherapy Major Product Offerings
7.11.4 Pfizer Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
7.12 Roche
7.12.1 Roche Company Summary
7.12.2 Roche Business Overview
7.12.3 Roche Cell-Based Immunotherapy Major Product Offerings
7.12.4 Roche Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.12.5 Roche Key News & Latest Developments
7.13 Takara Bio
7.13.1 Takara Bio Company Summary
7.13.2 Takara Bio Business Overview
7.13.3 Takara Bio Cell-Based Immunotherapy Major Product Offerings
7.13.4 Takara Bio Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.13.5 Takara Bio Key News & Latest Developments
7.14 Bausch Health
7.14.1 Bausch Health Company Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Cell-Based Immunotherapy Major Product Offerings
7.14.4 Bausch Health Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.14.5 Bausch Health Key News & Latest Developments
7.15 Apac Biotech
7.15.1 Apac Biotech Company Summary
7.15.2 Apac Biotech Business Overview
7.15.3 Apac Biotech Cell-Based Immunotherapy Major Product Offerings
7.15.4 Apac Biotech Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.15.5 Apac Biotech Key News & Latest Developments
7.16 Dendreon Pharmaceuticals (SanPower)
7.16.1 Dendreon Pharmaceuticals (SanPower) Company Summary
7.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
7.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Major Product Offerings
7.16.4 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.16.5 Dendreon Pharmaceuticals (SanPower) Key News & Latest Developments
7.17 JW CreaGene
7.17.1 JW CreaGene Company Summary
7.17.2 JW CreaGene Business Overview
7.17.3 JW CreaGene Cell-Based Immunotherapy Major Product Offerings
7.17.4 JW CreaGene Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.17.5 JW CreaGene Key News & Latest Developments
7.18 Green Cross Corp
7.18.1 Green Cross Corp Company Summary
7.18.2 Green Cross Corp Business Overview
7.18.3 Green Cross Corp Cell-Based Immunotherapy Major Product Offerings
7.18.4 Green Cross Corp Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.18.5 Green Cross Corp Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
